Genital Warts Market to Reach $2.64B by 2030 at 5.1% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Genital Warts Market Be By 2030 Compared To Its 2026 Market Size?

The size of the genital warts market has experienced strong growth in recent years. It is projected to expand from $2.06 billion in 2025 to $2.17 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.1%. The growth observed historically was influenced by the high prevalence of hpv infections, the availability of topical drugs, early adoption of ablative procedures, sexual health awareness programs, and established clinical treatment guidelines.

The market for genital warts is anticipated to experience robust expansion over the coming years. This market is projected to reach $2.65 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.1%. Factors contributing to this growth during the forecast period include a rise in hpv vaccination coverage, the emergence of novel topical agents, an increase in outpatient treatment options, proactive early screening initiatives, and patients’ preference for non-invasive care. Key trends anticipated for the forecast period encompass a surge in the acceptance of topical treatment therapies, heightened awareness of hpv-related infections, a rising demand for minimally invasive ablative treatments, the broader implementation of preventive hpv vaccination programs, and a greater utilization of home-based treatment solutions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

Which Important Drivers Are Guiding The Genital Warts Market Growth?

The expanding occurrence of sexually transmitted infections (STIs) is fueling the progression of the genital warts market. These infections, primarily transmitted via sexual contact including vaginal, anal, and oral intercourse, are instigated by bacteria, viruses, or parasites. The prevalence of STIs is on the rise due to increased sexual activity, insufficient protective measures, and limited access to educational and healthcare services. Genital warts, a frequent sexually transmitted infection, stem from particular human papillomavirus (HPV) strains and are transmitted through direct skin-to-skin contact during sexual encounters. For instance, in September 2025, the Centers for Disease Control and Prevention, a US-based government public health agency, indicated that more than 2.2 million cases of chlamydia, gonorrhea, and syphilis were reported in 2024. Consequently, the rising incidence of sexually transmitted infections (STIs) is a key factor driving the growth of the genital warts market.

What Are The Key Segment Divisions In The Genital Warts Market Segment Structure?

The genital warts market covered in this report is segmented –

1) By Drug Type: Imiquimod, Podophyllin, Podofilox, Trichloroacetic Acid

2) By Treatment: Chemical Treatment, Ablative Treatment, Preventive Treatment, Other Treatments

3) By Gender: Female, Male

4) By End Users: Hospitals, Clinics, Home Care Settings

Subsegments:

1) By Imiquimod: Imiquimod Cream 5%, Imiquimod Cream 3.75%

2) By Podophyllin: Podophyllin Resin 10%, Podophyllin Resin 25%

3) By Podofilox: Podofilox Gel 0.5%, Podofilox Solution 0.5%

4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%, Trichloroacetic Acid 50-70%

What Trends Are Influencing The Evolution Of The Genital Warts Market?

Leading companies in the genital warts market are focused on creating innovative treatment options, such as new dermatology drugs, to address the difficulties encountered by patients with genital warts. Dermatology drugs denote recently developed pharmaceuticals or therapeutic agents specifically designed to treat various dermatologic conditions, including genital warts. As an illustration, in March 2023, Verrica Pharmaceuticals Inc., a US-based dermatology pharmaceutical company, was granted New Chemical Entity (NCE) status for its prospective drug YCANTH. YCANTH is being developed for genital warts treatment and has successfully completed phase 2 trials. With the FDA NCE status, the company secures at least five years of protection from generic competition.

Which Organizations Are Engaged In The Genital Warts Market?

Major companies operating in the genital warts market are Merck & Co. Inc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, ANI Pharmaceuticals Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ Global AB, Cassiopea Inc, GlaxoSmithKline plc, Pfizer Inc, Bayer AG, Astellas Pharma Inc, Amgen Inc, Boehringer Ingelheim, Johnson & Johnson, Eli Lilly and Company, Novan Inc

Get The Full Genital Warts Market Report:

https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

Which Region Leads The Genital Warts Market In Terms Of Market Share?

North America was the largest region in the genital warts market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Genital Warts Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

Browse Through More Reports Similar to the Global Genital Warts Market 2026, By The Business Research Company

Vaginal Sling Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaginal-sling-global-market-report

Warts Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/warts-therapeutics-global-market-report

Genital Herpes Market Report 2026

https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795